Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q4 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.19 million versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.